Key Takeaways
- British lawmakers have designated the UK’s dependence on Palantir as an “unacceptable point of weakness” in a newly released parliamentary report
- The report identifies Palantir’s £330 million ($444 million) NHS data agreement as creating dangerous vendor lock-in exposure
- Legislators pointed to Peter Thiel’s political affiliations and Palantir’s defense sector work as fundamentally incompatible with British values
- The parliamentary panel is pushing for government officials to activate a 2027 exit provision in the NHS agreement and pursue domestic alternatives
- Palantir’s British operations chief rejected calls to terminate the contract, describing such moves as “frankly irresponsible”
A British parliamentary panel has launched a sharp critique of Palantir’s expanding role in UK public sector operations, cautioning that the nation’s growing dependence on the American data analytics company creates vulnerabilities around sensitive citizen information.
Palantir Technologies Inc., PLTR
On Wednesday, the Commons Science, Innovation and Technology Committee released a comprehensive 70-page assessment that identifies Palantir as a leading example of excessive dependence on a limited group of American technology vendors. Lawmakers characterized this dependency as representing an “unacceptable point of weakness.”
Shares of Palantir (PLTR) drew investor attention following the report’s publication, as market participants monitored potential implications from mounting political scrutiny in a crucial overseas market for the company.
The centerpiece of the committee’s concerns is Palantir’s seven-year, £330 million agreement with the National Health Service, secured in 2023. The contract aims to consolidate healthcare information from across NHS facilities into a unified platform, enabling medical professionals to reach decisions more rapidly.
According to NHS officials, the partnership has yielded “huge benefits for patients,” including accelerated cancer diagnostics and the treatment of thousands of additional patients monthly.
Lawmakers Demand Activation of Exit Provision
Notwithstanding these reported advantages, the committee is pressing government officials to invoke an exit provision written into the contract for 2027. Legislators want authorities to either identify a British alternative provider or develop an internal solution.
Parliamentarians expressed multiple reservations about Palantir extending beyond the technical parameters of the agreement. The assessment highlighted co-founder Peter Thiel’s political connections to Donald Trump and his previous public statements criticizing nationalized healthcare systems. The report also referenced Palantir’s contracts providing software solutions to American military and immigration enforcement agencies.
Lawmakers concluded this constituted a “clear mismatch with UK values” and cautioned that Britain’s digital modernization objectives risk being “derailed at any time by a decision taken outside our shores.”
Committee chairwoman Dame Chi Onwurah declared the UK was “seriously exposed” and advocated for technological independence in essential public sector functions.
Company Defends Agreement
Louis Mosley, Palantir’s UK chief executive, offered an immediate rebuttal. During a BBC radio interview, he noted the committee itself had recognized the NHS contract’s successful outcomes, making any termination recommendations “frankly irresponsible.”
Mosley emphasized that Palantir secured the agreement through a transparent and competitive procurement process, and that complete control over NHS data remains with the health service itself.
Foxglove, a British nonprofit organization that has actively campaigned against Palantir’s NHS involvement, endorsed the parliamentary findings. The group urged government officials to completely dissolve the contract.
The committee’s assessment also delivered broader criticism of governmental digital strategy, labeling the administration’s goal of achieving £45 billion in annual savings through digital transformation as “worryingly optimistic.”
Legislators suggested naming a cabinet-level minister specifically dedicated to overseeing the digital transformation initiative.
The UK government’s Department of Health had not issued a statement in response to media inquiries at press time.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
